The system is designed to reduce unnecessary biopsies, lesion correlation time, and improve overall diagnostic accuracy.
Hologic, Inc., announced recently it has expanded its ultrasound product line with its first cart-based system – the SuperSonic™ MACH 40.
The new system, which has multi-touch trackpad called SonicPad™, company officials said, is designed to enhance efficiency and accuracy while providing high-quality images and standard-setting imaging modes.
“With the addition of the SuperSonic MACH 40 system, we’ve successfully built a comprehensive portfolio of innovative, standard-setting breast ultrasound solutions designed to better meet the needs of breast imagers,” said Pete Valenti, Hologic’s division president of breast and skeletal health solutions. “The SuperSonic MACH 40 system embodies our commitment to delivering future-oriented solutions and was designed to help healthcare professionals reduce unnecessary biopsies by eliminating re-scans, reducing lesion correlation time, and improving overall diagnostic accuracy.”
According to company information, this system includes several new features:
When conducting ultrasound-guided biopsies, company officials said, clinicians using the system can use Needle P.L.U.S. imaging to see both the biopsy needles and anatomical structures in real time, allowing them to predict needle trajectory.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.